Phibro CEO Entity Sells 21K Shares After Conversion
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Phibro Animal Health Corp’s CEO-linked entity BFI Co., LLC converted 100,000 shares of Class B Common Stock into 100,000 shares of Class A Common Stock and then sold 21,120 Class A shares in open-market transactions from April 14–16 under a pre-arranged Rule 10b5-1 trading plan adopted on December 11, 2025. Reported weighted average sale prices ranged from about $53.80 to $59.83. After these trades, BFI held 117,000 Class A shares indirectly, while Jack Bendheim also directly held 16,840 Class A shares, showing that a substantial position remains after these planned sales.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
10 txns
Insider
BENDHEIM JACK, BFI Co., LLC
Role
President and CEO | 10% Owner
Sold
21,120 shs ($1.20M)
Approx. gross sale proceeds
$1.20M
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 100,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 100,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 5,190 | $54.5552 | $283K |
| Sale | Class A Common Stock | 1,850 | $54.8759 | $102K |
| Sale | Class A Common Stock | 2,623 | $56.2691 | $148K |
| Sale | Class A Common Stock | 3,618 | $57.2099 | $207K |
| Sale | Class A Common Stock | 799 | $58.1126 | $46K |
| Sale | Class A Common Stock | 6,548 | $59.0338 | $387K |
| Sale | Class A Common Stock | 492 | $59.6924 | $29K |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 19,496,034 contracts (Indirect, See);
Class A Common Stock — 117,000 shares (Indirect, See);
Class A Common Stock — 16,840 shares (Direct)
Footnotes (11)
- F1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10.
- F3. The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83.
- F5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73.
- F6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88.
- F7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22.
- F8. Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date.
- F9. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79.
- F10. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985.
- F11. The reported securities are directly held by Jack Bendheim.
Key Figures
Class B to Class A conversion: 100,000 shares
Total shares sold: 21,120 shares
Sale price example: $59.0338 per share
+4 more
7 metrics
Class B to Class A conversion
100,000 shares
Class B Common Stock converted into Class A Common Stock
Total shares sold
21,120 shares
Class A Common Stock sold in open-market transactions
Sale price example
$59.0338 per share
Weighted average price for 6,548-share sale on April 14
Highest reported weighted average price
$59.83 per share
Upper end of disclosed price range in one sale footnote
BFI post-transaction indirect holdings
117,000 shares
Class A Common Stock held indirectly after sales
Direct CEO holdings
16,840 shares
Class A Common Stock directly held by Jack Bendheim
Rule 10b5-1 plan adoption date
December 11, 2025
Date BFI Co., LLC adopted the trading plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, Class B Common Stock, Class A Common Stock, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class B Common Stock financial
"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A Common Stock financial
"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
pecuniary interest financial
"Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did PAHC report for Jack Bendheim and BFI Co., LLC?
A BFI Co., LLC entity linked to PAHC CEO Jack Bendheim converted 100,000 Class B shares into Class A and sold 21,120 Class A shares in open-market trades. These transactions occurred between April 14 and April 16 under a disclosed Rule 10b5-1 plan.
Were the PAHC insider sales made under a Rule 10b5-1 trading plan?
Yes. The footnotes state the reported sales were effected under a Rule 10b5-1 trading plan adopted by BFI Co., LLC on December 11, 2025. Such plans pre-schedule trades, indicating these sales were planned in advance rather than timed discretionarily.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates